See more news releases in: Magazines, Publishing & Information Services, Banking & Financial Services, Surveys, Polls and Research
Gilead Sciences Tops the 13th Annual BusinessWeek 50 Ranking
Coach falls from No. 1 to No. 16
This year's No. 1, Gilead Sciences, scored a huge success earlier this decade when it sensed an opening for HIV drugs that were simpler and cheaper than standard treatments, which required patients to pop dozens of different pills throughout the day. Gilead's researchers responded with a new manufacturing process allowing them to produce compounds of several drugs to be released into the bloodstream at different times. The result was a daily-dose pill that replaced the old drug cocktails for a fraction of the cost. Now the company is going after another big market: patient-friendly treatments for hepatitis C, a chronic liver disease that affects 170 million people worldwide.
Given the carnage on Wall Street and in the economy, you might expect considerable turnover in the BusinessWeek 50. While some notable companies dropped off this year -- for instance, UnitedHealth Group, No. 14 in 2008 -- the 2009 list includes a surprising number of return performers. Among the Class of 2009, 33 companies were repeats from last year's ranking, the largest number in the history of the BW 50.
All these companies know there's no guarantee of success. Look through this year's rankings, and you'll see a number of current high achievers at risk of seeing their franchises disrupted by upstart rivals. For Starbucks (No. 32), the threat is coming from McDonald's and Dunkin' Donuts, which are undercutting the coffee giant on price. For Microsoft (No. 8), the spread of cheap -- or even free -- Internet applications offered by Google (No. 35) is threatening its hegemony over the desktop computer. And Best Buy (No. 9) is seeing its CD and video franchise threatened by the digital downloading services run by the likes of Amazon and Apple. But these challenged companies have a history of rising to the occasion and may prove that they can be innovative -- and disruptive -- players once again.
BusinessWeek's BW 50 ranking is featured in the
BusinessWeek 50
Class of 2009
Rank Company
1 Gilead Sciences
2 CF Industries Holdings
3 Diamond Offshore
4 Windstream
5 Colgate-Palmolive
6 C.H. Robinson Worldwide
7 Exelon
8 Microsoft
9 Best Buy
10 MasterCard
11 Precision Castparts
12 Varian Medical Systems
13 Avon Products
14 Schlumberger
15 Apple
16 Coach
17 IntercontinentalExchange
18 Questar
19 Fastenal
20 Nucor
21 Verizon
22 Express Scripts
23 Amazon.com
24 MEMC Electronic Materials
25 CB Richard Ellis
26 Coca-Cola
27 Apollo Group
28 Expeditors International of Washington
29 Noble
30 Nasdaq OMX Group
31 Cognizant Technology Solutions
32 Starbucks
33 Waters
34 EQT
35 Google
36 CME Group
37 Manitowoc
38 AT&T
39 Allegheny Technologies
40 PepsiCo
41 Intuitive Surgical
42 Nike
43 Occidental Petroleum
44 PNC Financial Services
45 Autodesk
46 Robert Half International
47 TJX
48 AES
49 Northern Trust
50 Abercrombie & Fitch
SOURCE BusinessWeek
Back to top
RELATED LINKS
http://www.businessweek.com/bw50
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".
- Site Preview
-
Close Site Preview
-
View FullScreen

